References: Medication rationalisation in palliative care
Ascend Study Collaborative Group, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med 2018;379(16):1529-39. https://www.ncbi.nlm.nih.gov/pubmed/30146931
Chalmers JD, Laska IF, Franssen FME, Janssens W, Pavord I, Rigau D, et al. Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. Eur Respir J 2020;55(6). https://www.ncbi.nlm.nih.gov/pubmed/32366483
Curtin D, Gallagher P, O'Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 2021;50(2):465-71. https://www.ncbi.nlm.nih.gov/pubmed/32997135
Deardorff WJ, Cenzer I, Nguyen B, Lee SJ. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials. JAMA Intern Med 2022;182(1):33-41. https://www.ncbi.nlm.nih.gov/pubmed/34807231
Dunning TL. Palliative and End-of-Life Care: Vital Aspects of Holistic Diabetes Care of Older People With Diabetes. Diabetes Spectr 2020;33(3):246-54. https://www.ncbi.nlm.nih.gov/pubmed/32848346
Hung KC, Lee LW, Liew YX, Krishna L, Chlebicki MP, Chung SJ, et al. Antibiotic stewardship program (ASP) in palliative care: antibiotics, to give or not to give. Eur J Clin Microbiol Infect Dis 2022;41(1):29-36. https://www.ncbi.nlm.nih.gov/pubmed/34414518
Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Support Care Cancer 2015;23(1):71-8. https://www.ncbi.nlm.nih.gov/pubmed/24975044
Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2013;97(2):437-44. https://www.ncbi.nlm.nih.gov/pubmed/23255568
Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020;201(9):e56-e69. https://www.ncbi.nlm.nih.gov/pubmed/32283960
Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, et al. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. Med J Aust 2019;210(4):174-9. https://www.ncbi.nlm.nih.gov/pubmed/30771226
Tardy B, Picard S, Guirimand F, Chapelle C, Danel Delerue M, Celarier T, et al. Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. J Thromb Haemost 2017;15(3):420-8. https://www.ncbi.nlm.nih.gov/pubmed/28035750
Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology 2022;162(4):1334-42. https://www.ncbi.nlm.nih.gov/pubmed/35183361
Tran HA, Gibbs H, Merriman E, Curnow JL, Young L, Bennett A, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust 2019;210(5):227-35. https://www.ncbi.nlm.nih.gov/pubmed/30739331
White C, Noble SIR, Watson M, Swan F, Allgar VL, Napier E, et al. Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study. Lancet Haematol 2019;6(2):e79-e88. https://www.ncbi.nlm.nih.gov/pubmed/30709436
